Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis

American Journal of Pathology

Volumn 173, Issue 4, 2008, Pages 1029-1041

  Tsutsui, Shigeki ^a   Hahn, Jennifer N ^a   Johnson, Trina A ^a   Ali, Zenobia ^a   Jirik, Frank R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PRION PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; IMMUNIZATION; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; T LYMPHOCYTE;

EID: 53149101680     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.071062     Document Type: Article

References (54)

1. Taylor DR, Hooper NM: The prion protein and lipid rafts. Mol Membr Biol 2006, 23:89-99
2. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ: Scrapie prion proteins are synthesized in neurons. Am J Pathol 1986, 122:1-5
3. Brown DR, Besinger A, Herms JW, Kretzschmar HA: Microglial expression of the prion protein. Neuroreport 1998, 9:1425-1429
4. Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS: Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 2002, 368:81-90
5. Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, Veiga SS, Juliano MA, Roesler R, Walz R, Minetti A, Izquierdo I, Martins VR, Brentani RR: Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 2000, 76:85-92
6. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB: Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001, 314:1209-1225
7. Spielhaupter C, Schatzl HM: PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 2001, 276:44604-44612
8. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR: Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002, 21:3307-3316
9. Kurschner C, Morgan JI: Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res Mol Brain Res 1996, 37:249-258
10. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, Onodera T: Prions prevent neuronal cell-line death. Nature 1999, 400:225-226
11. Brown DR, Nicholas RS, Canevari L: Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 2002, 67:211-224
12. Wong BS, Liu T, Li R, Pan T, Petersen RB, Smith MA, Gambetti P, Perry G, Manson JC, Brown DR, Sy MS: Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 2001, 76:565-572
13. Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H, Lehmann S, Favier A: Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 2003, 278:9064-9072
14. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, Brentani RR: Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999, 40:1679-1682
15. Weise J, Sandau R, Schwarting S, Crome O, Wrede A, Schulz-Schaeffer W, Zerr I, Bahr M: Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke 2006, 37:1296-1300
16. Shyu WC, Lin SZ, Chiang MF, Ding DC, Li KW, Chen SF, Yang HI, Li H: Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 2005, 25:8967-8977
17. Isaacs JD, Jackson GS, Altmann DM: The role of the cellular prion protein in the immune system. Clin Exp Immunol 2006, 146:1-8
18. Dodelet VC, Cashman NR: Prion protein expression in human leukocyte differentiation. Blood 1998, 91:1556-1561
19. Burthem J, Urban B, Pain A, Roberts DJ: The normal cellular prion protein is strongly expressed by myeloid dendritic cells. Blood 2001, 98:3733-3738
20. Li R, Liu D, Zanusso G, Liu T, Fayen JD, Huang JH, Petersen RB, Gambetti P, Sy MS: The expression and potential function of cellular prion protein in human lymphocytes. Cell Immunol 2001, 207:49-58
21. Liu T, Li R, Wong BS, Liu D, Pan T, Petersen RB, Gambetti P, Sy MS: Normal cellular prion protein is preferentially expressed on subpopulations of murine hemopoietic cells. J Immunol 2001, 166:3733-3742
22. Ford MJ, Burton LJ, Morris RJ, Hall SM: Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002, 113:177-192
23. Mabbott NA, Brown KL, Manson J, Bruce ME: T-lymphocyte activation and the cellular form of the prion protein. Immunology 1997, 92:161-165
24. de Almeida CJ, Chiarini LB, da Silva JP, PM ES, Martins MA, Linden R: The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol 2005, 77:238-246
25. Ballerini C, Gourdain P, Bachy V, Blanchard N, Levavasseur E, Gregoire S, Fontes P, Aucouturier P, Hivroz C, Carnaud C: Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells. J Immunol 2006, 176:7254-7262
26. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C: Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582
27. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW: Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002, 125:1297-1308
28. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC: TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998, 4:78-83
29. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, Warren K, Power C: A1 adenosine receptor up-regulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 2004, 24:1521-1529
30. Johnston JB, Silva C, Gonzalez G, Holden J, Warren KG, Metz LM, Power C: Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis. Ann Neurol 2001, 49:650-658
31. Overbergh L, Valckx D, Waer M, Mathieu C: Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999, 11:305-312
32. Martin-Saavedra FM, Flores N, Dorado B, Eguiluz C, Bravo B, Garcia-Merino A, Ballester S: Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis. Mol Immunol 2007, 44:3597-3607
33. Hemmer B, Archelos JJ, Hartung HP: New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002, 3:291-301
34. Kubosaki A, Nishimura-Nasu Y, Nishimura T, Yusa S, Sakudo A, Saeki K, Matsumoto Y, Itohara S, Onodera T: Expression of normal cellular prion protein (PrP(c)) on T lymphocytes and the effect of copper ion: analysis by wild-type and prion protein gene-deficient mice. Biochem Biophys Res Commun 2003, 307:810-813
35. Bainbridge J, Walker KB: The normal cellular form of prion protein modulates T cell responses. Immunol Lett 2005, 96:147-150
36. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573
37. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240
38. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141
39. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285
40. Tsutsui S, Noorbakhsh F, Sullivan A, Henderson AJ, Warren K, Toney-Earley K, Waltz SE, Power C: RON-regulated innate immunity is protective in an animal model of multiple sclerosis. Ann Neurol 2005, 57:883-895
41. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD: Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000, 48:893-901
42. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD: Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 2002, 61:23-32
43. Bar-Or A, Oliveira EM, Anderson DE, Hafler DA: Molecular pathogenesis of multiple sclerosis. J Neuroimmunol 1999, 100:252-259
44. Westergard L, Christensen HM, Harris DA: The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007, 1772:629-644
45. Mattei V, Garofalo T, Misasi R, Circella A, Manganelli V, Lucania G, Pavan A, Sorice M: Prion protein is a component of the multimolecular signaling complex involved in T cell activation. FEBS Lett 2004, 560:14-18
46. Paar C, Wurm S, Pfarr W, Sonnleitner A, Wechselberger C: Prion protein resides in membrane microclusters of the immunological synapse during lymphocyte activation. Eur J Cell Biol 2007, 86:253-264
47. Stuermer CA, Langhorst MF, Wiechers MF, Legler DF, Von Hanwehr SH, Guse AH, Plattner H: PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction. FASEB J 2004, 18:1731-1733
48. Cashman NR, Loertscher R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC, Bendheim PE: Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990, 61:185-192
49. MacMicking J, Xie QW, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350
50. Encinas JM, Manganas L, Enikolopov G: Nitric oxide and multiple sclerosis. Curr Neurol Neurosci Rep 2005, 5:232-238
51. Steinman L: A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-145
52. Suryani S, Sutton I: An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J Neuroimmunol 2007, 183:96-103
53. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klonowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L: Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508
54. Muller DM, Pender MP, Greer JM: A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction. Acta Neuropathol (Berl) 2000, 100:174-182